• O-GlcNAcylation Rewires Wnt-Driven Bone Formation

  2026-08-14

  The reference study identifies O-GlcNAcylation as a metabolic and post-translational mechanism that enables Wnt3a-driven osteoblastogenesis. Its central finding is that Wnt3a modifies PDK1 at Ser174, stabilizing PDK1 and redirecting glucose toward aerobic glycolysis, thereby supporting bone formation and fracture healing.

• Z-VDVAD-FMK: Apoptosis or Pyroptosis?

  2026-08-14

  Z-VDVAD-FMK is an irreversible, cell-permeable inhibitor for dissecting caspase-2-linked apoptosis. This guide explains how to use it alongside mitochondrial, proteolytic, and pyroptosis readouts to avoid misinterpreting persistent cell death in cancer research.

• Isoproterenol Sulfate Dihydrate: Lab Guide

  2026-08-13

  This scenario-based guide shows how Isoproterenol sulfate dihydrate (SKU C6402) can improve experimental control in beta-adrenergic, viability, proliferation, and human pacemaker-model workflows. It connects formulation, storage, dosing, and data interpretation to current SAN-plexus assembloid research.

• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-08-13

  Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge to separate intrinsic pacemaker behavior from neural modulation in human PSC-derived cardiac assembloids. The workflow combines dose-response analysis, cAMP/PKA pathway readouts, and electrophysiology for practical cardiovascular research.

• EZ Cap Cy5 Firefly Luciferase mRNA Guide

  2026-08-12

  EZ Cap Cy5 Firefly Luciferase mRNA combines a Cap1-capped, 5-moUTP modified mRNA transcript with covalent Cy5 labeling and Firefly Luciferase expression. The design separates delivery tracking by fluorescence from functional translation readout by bioluminescence, while product specifications define a 1921-nucleotide transcript supplied at 1 mg/mL.

• Liproxstatin-1 Workflows for Ferroptosis Research

  2026-08-12

  Build more discriminating ferroptosis assays with Liproxstatin-1 as a pathway-focused rescue control rather than a general cytoprotectant. This guide connects GPX4-deficient cell protection, lipid-peroxidation imaging, renal injury models, and a carefully bounded extension into Candida albicans research.

• PNU 74654: Strategic Wnt Pathway Inhibition

  2026-08-11

  A translational framework for using PNU 74654 to interrogate Wnt/β-catenin biology, informed by evidence on the WNT5a/GSK3/β-catenin axis in muscle progenitors. The article distinguishes mechanistic rationale from direct validation, outlines practical assay design, and positions this Wnt signaling pathway inhibitor for disciplined cancer and stem cell research.

• Deferoxamine (DeferoxamineB) in Cell Assays

  2026-08-11

  Learn how Deferoxamine (DeferoxamineB), SKU BA2746, can improve experimental control in viability, proliferation, and regulated cell-death studies. This scenario-based guide connects iron chelation, assay compatibility, solution preparation, interpretation, and practical product-selection criteria.

• Malate in Metabolic-Immune Assay Design

  2026-08-10

  Malate and (S)-2-hydroxysuccinic acid are more than TCA cycle markers: they can help structure experiments linking mitochondrial redox, metabolic flux, and immune signaling. This guide translates recent PDHA1 succinylation findings into practical assay decisions while clearly separating established biology from testable malate-based hypotheses.

• Isoproterenol sulfate dihydrate in SAN assays

  2026-08-09

  Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge in human PSC-derived sinoatrial node and cardiac plexus assembloids. This workflow connects acute cAMP/PKA pathway responses with pacemaker maturation, neural modulation, and reproducible cardiovascular research rather than treating agonist sensitivity as a standalone endpoint.

• Grazoprevir Hydrate: From Target to Regimen

  2026-08-08

  Grazoprevir hydrate, also known as MK-5172 hydrate, is examined from molecular target through clinical regimen design. This evidence-led guide connects hepatitis C virus replication inhibition with genotype, resistance, comorbidity, pharmacokinetic, and assay decisions.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody Guide

  2026-08-07

  This guide explains how to use HRP Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1223, to detect rabbit primary antibodies in Western blotting, ELISA, IHC, and IC. It also defines storage, assay controls, optimization boundaries, and situations where this reagent should not be treated as a validated diagnostic or species-independent detection reagent.

• Isoproterenol Sulfate Dihydrate: Advancing Human Cardiac Ass

  2026-08-07

  Isoproterenol sulfate dihydrate empowers precise, reproducible modeling of beta-adrenergic signaling in human cardiac assembloid systems. This guide delivers actionable workflows, troubleshooting strategies, and insight into how APExBIO's high-purity reagent enables next-generation neuro-cardiac research.

• IWP-2: Potent Wnt Production Inhibitor for Cancer Research

  2026-08-06

  IWP-2 is a highly potent, selective small-molecule Wnt production inhibitor that targets Porcupine (Porcn), blocking Wnt/β-catenin pathway activity at nanomolar concentrations. Its efficacy is validated in both cancer cell lines and regenerative models, with well-defined solubility and storage protocols. This article details IWP-2’s mechanism, biological rationale, and practical considerations for scientific use.

• Grazoprevir/Elbasvir: Advances in HCV Genotype 1 and 4 Thera

  2026-08-06

  The reference study by Vallet-Pichard and Pol provides a comprehensive analysis of the fixed-dose combination of grazoprevir (MK-5172 hydrate) and elbasvir for hepatitis C virus (HCV) infection. Their review highlights this regimen’s high efficacy, tolerability, and applicability across challenging patient populations, marking a significant advance over previous interferon-based protocols.

8458 records 3/564 page Previous Next 12345 下5页 Last page